Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination in Hypertension and Hyperlipidemia
NCT03009487Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jan 2017
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, olmesartan, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by Daewoong Pharmaceutical. Started Jan 2017; status: completed.
02
Drugs
amlodipineolmesartanrosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03009487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009487.